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Summary Background: Spirometry is increasingly implemented in general practice,
while the ability of general practitioners (GPs) to interpret flow–volume curves (FV
curves) has been questioned. Furthermore, the role of spirometry in the GPs
decision-making process has barely been studied.
Aim: To compare the achievements of trained GPs in spirometric diagnosis with an
expert consensus panel (1) and to assess the influence of spirometry on the GPs
decision-making (2).
Method: Twelve cases including a wide range of FV curves were interpreted by
39 GPs as well as the expert panel. Diagnostic test characteristics were calculated
using multi-level analysis and summarised by diagnostic odds ratios (DOR).
Differences in decision-making indicators were expressed as odds ratios and 95%
confidence intervals.
Results: Normal FV curves (DOR 65.0) and obstructive FV curves (DOR 48.9)
were reasonably well diagnosed, while rare and mixed pathological patterns
achieved considerably lower scores (DOR 3.8). Intermediate scores were obtained in
the recognition of incorrect test manoeuvres (DOR 24.4). Spirometry influenced the
GPs decision-making in reducing the number of alternative diagnoses (OR 0.266
[0.200, 0.353]), but also increased referral rates (7.26 [4.71, 11.2]) and the use of
diagnostic prednisolone courses (4.55 [3.12, 6.64]) substantially.
Conclusion: Trained GPs were able to differentiate between normal and
obstructive disease patterns, while FV curves suggestive of rare and mixed
pathology were often missed. Spirometry seems to influence the decision-making
process of the GP; whether this represents an initial or a more sustained effect
remains to be evaluated in studies of daily primary care practice.
& 2004 Elsevier Ltd. All rights reserved.
ARTICLE IN PRESS
KEYWORDS
Spirometry;
Primary care;
Interpretation;
Decision-making
*Corresponding author. Department of General Practice, Caphri Research Institute, Maastricht University, P.O. Box 616, 6200 MD
Maastricht, The Netherlands. Tel.: þ 31-43-3882315; fax: þ 31-43-3619344.
E-mail address: niels.chavannes@hag.unimaas.nl (N. Chavannes).
0954-6111/$ - see front matter & 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.rmed.2004.04.004
Respiratory Medicine (2004) 98, 1124–1130
Introduction
In general practice, medical history taking and
physical examination are the most important
instruments to establish diagnosis and initiate
treatment. Diagnostic tools originating from sec-
ondary care settings such as electrocardiography1,2
and spirometry3–5 are increasingly used in primary
care and the results are being interpreted by
general practitioners (GPs). Access to spirometry
in primary care has increased rapidly in the past
years, surveys ranging from 21%6 (1998) to 77%
(2001) in the UK.7 By contrast, spirometer utilisa-
tion is hampered by insufficient training: less than
half are used to diagnose COPD.7 Several national
and international guidelines consider formal spiro-
metric testing essential to establish a diagnosis of
COPD,4,8,9 while education in its use has been
identified as a major goal for primary care
physicians.4,10,11
However, the value of spirometry in differentiat-
ing between specific respiratory disease patterns
still needs to be assessed in general practice. Most
authors focus on the quality of spirometry test
performance,5,12,13 while studies investigating the
interpretative skills of physicians report rather
disappointing results, both in primary5 and second-
ary care14,15 setting.
A number of studies in COPD and asthma suggest
that spirometry could reduce both under- and
overdiagnosis of obstructive airway disease in
general practice,16–18 which might influence dis-
ease management. Adjustment of treatment after
spirometry has been reported in 4–25% of patients
with mostly asthmatic complaints.19,20 However,
the direct influence of spirometry on the decision-
making process of GPs has not been assessed.
Therefore, the aim of the current study was to
determine the achievements of GPs in differentiat-
ing between various chronic respiratory diseases
when spirometry is provided as a supplementary
diagnostic tool. In addition, we investigated the
impact of the flow–volume curve on the GPs
decision-making process.
Methods
Participants and spirometry training
GPs with an interest in spirometry were recruited
from the general practice networks of the Nijme-
gen and Maastricht Universities in the Netherlands.
Most of these GPs already used spirometry in daily
practice, had received previous training and were
motivated to assess their skills. Additionally, GPs
involved in the vocational training in the Nijmegen
and Maastricht regions were invited by postal
mailing to participate in the study.
Participating GPs received a standardised post-
graduate spirometry training course (two three-
hours sessions with an interval of one month), and
could bring their newly acquired spirometric knowl-
edge and skills into practice for a period of six to
nine months before the study started. The spiro-
metry course was based on a format widely used in
the Netherlands. During the first session the focus
was mainly on the pathogenesis and clinical
characteristics of asthma, COPD and other chronic
respiratory diseases; theoretical concepts of lung
function testing; execution of spirometry tests; and
practical guidelines and strategies for spirometry
interpretation. The second session was mainly used
to discuss actual case descriptions submitted by
either the participants or course leaders. Training
was provided by a pulmonologist and an experi-
enced lung function technician. Interactive educa-
tion and feedback on the spot were emphasized
throughout the course.
Standardised case descriptions
A set of 12 standardised case descriptions was
constructed, based on actual patients from two
general practices from our academic networks. The
cases were designed in cooperation with a pulmo-
nologist and a GP with ample experience in the
field of chronic respiratory diseases. The case set
included a range of typical flow–volume curves
suggesting mild obstruction (n ¼ 1); moderate
obstruction (n ¼ 1); severe obstruction (n ¼ 2);
rare pattern of restriction (n ¼ 1); fixed upper
airways obstruction (n ¼ 1); mixed pattern of both
obstruction and restriction (n ¼ 1); incorrect test
manoeuvres (n ¼ 2); and normal curves (n ¼ 3).
The participating GPs worked through two sets of
six cases each, which were assessed in random
order within a period of one year. Randomisation
codes were prepared by a fellow-researcher who
was not involved in the study and stored in sealed
envelopes until use. Data were collected in the
period July 1999 through April 2001.
A research assistant visited the GPs in their
practice. For each case, a concise medical history
and results of the physical examination were
presented to the GP first. Subsequently, absolute
and predicted postbronchodilator spirometry test
results (including FEV1, FEV1/FVC and flow–volume
curves) were provided. After having assessed a
case, GPs had to select one spirometric diagnosis
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from a preformulated list. An example of the case
structure is depicted in Fig. 1.
Before the study, the 12 paper cases had been
judged by an independent expert panel consisting
of two pulmonologists, a pulmonary physiologist
and a GP with specific expertise in the pulmonary
field. The panel reached consensus on the spiro-
metric and clinical diagnoses of the paper cases
during a panel discussion meeting, while no cases
were excluded. The panel meeting was audiotaped
and independently scored by two of the authors (NC
and TS) in order to establish the panels’ final
diagnosis andFwhen applicableFalternative diag-
noses for each case. There was 100% agreement
between the two observers with respect to the
panels’ final and alternative diagnoses. The panel
consensus diagnoses served as ‘the gold standard’
in the subsequent evaluation of the GPs’ diagnostic
achievements.
Outcome measures
To assess the diagnostic achievements of GPs with
regard to interpretation of spirometry, the follow-
ing four outcome categories were considered most
relevant and contrasting from a clinical point of
view: (1) bronchial obstruction (from mild to
severe); (2) rare respiratory pathology (i.e., re-
striction, fixed upper airways obstruction, mixed
pattern); (3) normal lung function; and (4) incor-
rect test manoeuvre.
In addition, the impact of spirometry on the GPs
decision-making process was assessed using four
indicators: (1) diagnostic uncertainty (size of differ-
ential diagnosis, i.e. the number of alternative
diagnoses considered by the GPs while assessing a
case); (2) probability of prescribing respiratory
medication; (3) probability of initiating a diagnostic
prednisolone course, a commonly used test (albeit
its’ value is uncertain); and (4) probability of
referral to a pulmonologist and/or cardiologist.
These process indicators of GP decision-making were
assessed before and after the results of spirometry
were shown to the GPs (Fig. 1).
Statistical analyses
First, the agreement between the GPs’ interpreta-
tions and the expert panels ‘gold standard’
diagnoses was investigated univariately using the
SPSSs software package (Version 9.0 for Windows).
Subsequently, multi-level linear and logistic model-
ling was used to account for the intra-cluster
correlation induced by the fact that each GP
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Figure 1 Schematic representation of case structure ‘mild to moderate COPD’.
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assessed more than one case. SASs software
(Release 6.12 for Windows) was used for these
multi-level analyses.
The following diagnostic test characteristics
were calculated for each outcome measure:21
positive and negative predictive values (further
referred to as PPV and NPV, respectively), positive
and negative likelihood ratios (LRþ and LR,
respectively) and the diagnostic odds ratio (DOR).
PPV expresses the probability of disease in subjects
with a positive test result, NPV the probability of
absence of disease in subjects with a negative test
result. LRþ is the ratio of the probability of a
positive test in subjects with disease and the
probability of a positive test in subjects without
disease. Conversely, LR is the ratio of the
probability of a negative test in subjects with
disease and the probability of a negative test in
subjects without disease. A diagnostic test is better
the more LR differs from 1, that is, greater than 1
for LRþ and lower than 1 for LR. Finally, the DOR
summarises the overall discrimination of a diag-
nostic test with a dichotomous outcome. In fact, it
is the ratio of LRþ and LR. Therefore, a
diagnostic test is useless if DOR¼ 1.21
After the four indicators of decision-making were
dichotomised (1 vs.41 diagnosis; 0 vs. 1 diagnostic
prednisolone course; 0 vs. 1 or more referrals; 0 vs.
1 or more prescriptions), the before–after spiro-
metry measurements were compared using multi-
level logistic regression analysis and expressed as
odds ratios with 95% confidence intervals (95% CI).
Results
General practitioners
Thirty-nine (39) GPs participated in the study. Three
GPs dropped out during the study, one because of
early retirement, the others due to loss of interest.
These three GPs completed one set of six cases,
instead of both sets. Table 1 shows that the study
population consisted predominantly of middle-aged
male doctors who had been using spirometry in their
daily practice for a mean of 4.3 (SD 3.7) years,
having received 4.2 (SD 4.9) hours of spirometry
training in the year preceding the experiment.
Diagnostic achievements by GPs
Altogether, the GPs assessed 444 cases. Table 2
shows the agreement between GP judgements and
expert panel for each of the diagnostic outcome
categories. Concordance with the expert panel
regarding obstruction was present in 91.3% [95% CI
86.8, 95.8] of cases, followed by normal spirometry
obtaining 77.9% [95% CI 70.2, 85.6] correct
answers, while incorrect manoeuvres reached a
score of 64.9% [95% CI 54.0, 75.8], and rare
pathological curves were recognised in 41.3% [95%
CI 32.1, 50.5] of cases.
Table 3 shows that normal and obstructive curves
were characterised by high DORs: 65.0 and 48.9,
respectively. By contrast, rare pathological curves
obtained a low DOR of 3.8. Scoring of an incorrect
test manoeuvre generated an intermediate DOR of
24.4. The negative predictive values (probability of
righteously ruling out disease) varied between 0.93
and 0.96, except for rare pathology, which reached
0.82. Positive predictive values (probability of
righteously labelling disease) however, revealed a
range of values between 0.87 (normal curves) and
0.49 (rare pathology).
Indicators of GPs decision-making
Before spirometry, GPs considered an average of
2.05 diagnoses per case, with a maximum of eight,
while after spirometry this was reduced to a mean
of 1.35, with a maximum of six. Table 4 quantifies
this significant reduction of diagnostic uncertainty:
41 diagnosis is considered in 59.6% [55.1, 64.1] of
cases before spirometry, while after spirometry41
diagnosis is considered in 31.2% [26.9, 35.5] of
cases (OR 0.266 [0.200, 0.353]. Conversely, spiro-
metry significantly increases the number of diag-
nostic prednisolon courses and the referral rate,
while the proportion of cases where medication is
prescribed increases, but not significantly. The
probability of diagnostic prednisolon testing rises
three-fold, from 8.0% [5.5, 10.5] to 27.6% [23.5,
31.7] per case (OR 4.55 [3.12, 6.64]) as a result of
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Table 1 Characteristics of participating general
practitioners (n ¼ 36a).
Male/female 33/3
Age, years 48 (5.1)
Patients enlisted per GP, number 2086 (712)
Surgery hours per week, hours 43.6 (12.7)
Use of spirometer in daily patient
care, yes/no
35/1
Duration of spirometry utilisation,
years
4.3 (3.7)
Spirometry training in previous year,
hours
4.2 (4.9)
Values are means (standard deviation) unless stated
otherwise.
aData missing on 3 GPs who dropped out during the study.
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Table 3 Predictive values, likelihood ratios and diagnostic odds ratios for general practitioners diagnoses.
PPV NPV LRþ LR DOR
Normal spirometry 0.87 0.93 15.16 0.23 65.0
Obstructive disease 0.75 0.96 5.18 0.11 48.9
Incorrect manoeuvre 0.68 0.93 9.23 0.38 24.4
Rare pathology 0.49 0.82 2.66 0.70 3.8
PPV: positive predictive value; NPV: negative predictive value; LRþ : positive likelihood ratio; LR: negative likelihood ratio;
DOR: diagnostic odds ratio.
Table 4 Impact of flow–volume curve on indicators of the decision-making process in general practitioners.
Process indicators Before F=V-curve After F=V-curve OR (95% CI)
Diagnostic uncertaintya 59.6% (55.1, 64.1) 31.2% (26.9, 35.5) 0.266 (0.200,.353)
Prednisolon course 8.0% (5.5, 10.5) 27.6% (23.5, 31.7) 4.55 (3.12, 6.64)
Referral rate 6.0% (3.8, 8.2) 31.7% (27.4, 36.0) 7.26 (4.71, 11.2)
Medication prescription 36.5% (32.0, 41.0) 39.4% (34.9, 43.9) 1.14 (0.87, 1.50)
Numbers are percentages with 95% confidence intervals.
aProportion of 41 diagnoses in the differential diagnosis.
Table 2 Agreement between expert panel and GP judgement for the presence (or absence) of obstructive
disease (A), rare pathology (B), normal spirometry (C), and incorrect manoeuvre (D).
Expert panel judgement
(A)
Obstruction No obstructiona
GP judgement Obstruction 136 (31) 52 (12) 188 (42)
No obstructiona 13 (3) 243 (55) 256 (58)
149 (34) 295 (66) 444 (100)
(B)
Rare pathology No rare pathologyb
GP judgement Rare pathology 45 (10) 52 (12) 97 (22)
No rare pathologyb 64 (14) 283 (64) 347 (78)
109 (25) 335 (75) 444 (100)
(C)
Normal spirometry Not normal spirometryc
GP judgement Normal Spirometry 88 (20) 17 (4) 105 (24)
Not normal spirometryc 25 (6) 314 (71) 339 (76)
113 (25) 331 (75) 444 (100)
(D)
Incorrect Manoeuvre Not incorrect manoeuvred
GP judgement Incorrect Manoeuvre 48 (11) 26 (6) 74 (17)
Not incorrect manoeuvred 26 (6) 344 (77) 370 (83)
74 (17) 370 (83) 444 (100)
Percentages of total number of cases within parenthesis.
aEither rare pathology, normal spirometry, or incorrect manoeuvre.
bEither obstruction, normal spirometry, or incorrect manoeuvre
cEither obstruction, rare pathology, or incorrect manoeuvre.
dEither obstruction, rare pathology, or normal spirometry.
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spirometry. The probability of referral changes
from 6.0% [3.8, 8.2] to 31.7% [27.4, 36.0] as a
result of spirometry (OR 7.26 [4.71, 11.2]).
Discussion
The present study demonstrates for the first time
the reasonable diagnostic achievements of trained
GPs with regard to commonly encountered spiro-
metric patterns. Curves of obstructive airways
disease as well as the physiological can be con-
sidered the more prevalent conditions, as opposed
to patterns suggestive of restriction or fixed upper
airways obstruction, which GPs can be expected to
be less familiar with. On the whole, the positive
predictive values are lower than the negative
predictive values. This reflects the fact that in
primary care it remains more difficult to label a
disease than to exclude it, due to the lower a priori
probability. The relatively low positive predictive
value of an incorrect test manoeuvre illustrates the
need to emphasise the importance of quality
assessment of the flow–volume curve, which should
precede interpretation. The low diagnostic achieve-
ments in the less prevalent categories points out the
paradoxical necessity of recognising patterns one
does not understand. Another explanation might be
that dynamic spirometry is of limited use in
differentiating between normal and restrictive dis-
ease, thus contributing to the low diagnostic yield.
These elements should receive considerable atten-
tion in future spirometry courses, professional
supervision or automated supportive software.
The significant influence of the flow–volume
curve on the trained GPs’ decision-making is
expressed in a reduction of the number of alter-
native diagnoses but an increase in referral rates
and diagnostic prednisolone courses. Thus, the
flow–volume curve seems to support establishing
a diagnosis in patients with respiratory morbidity,
but probably leads to an increased use of additional
diagnostic procedures or specialist care, at least
initially. This could partially reflect the relatively
high prevalence of pathology in this specific case-
set, warranting further work-up. Another explana-
tion could be that the number of options was
limited; for example, an option to repeat spirome-
try to verify correctness of the manoeuvre was
missing, possibly leading to increased prednisolone
testing or referral instead. The current design does
not allow us to deduct if this initial increase would
be sustained in time, nor does it predict the exact
effect size in daily practice.
Spirometers are increasingly available but seem
underused,7 while doctors have been observed to
overestimate their actual interpretative skills in
spirometry,22 as well as in ECGs.23 This underlines
that training is a prerequisite for meaningful
implementation of advanced diagnostic tools in
primary care. Both quality assessment and pattern
recognition have been part of our standardised
spirometry training course, which took place 6–9
months preceding the measurements, allowing the
primary care physicians to integrate skills in daily
practice. The format and duration of the training
were directly derived from a common postgraduate
spirometry course, which has been attended by
large numbers of Dutch primary care physicians in
the past few years.
The results of the present study reflect the ability
of trained GPs to diagnose this specific case-set.
Therefore, we do not pretend to reflect actual
prevalences of the disease patterns within the
constitution of the cases. By analysing spirometric
patterns separately this over-representation is cor-
rected for. Consequently, the multi-level analysis was
performed to account for intra-cluster correlation
within the GPs. However, it remains to be investi-
gated what the results will be in a real-life setting,
with actual patients and less or even untrained GPs.
The case-set structure allowed us to compare the
level of pattern recognition quite precisely with an
expert panel, which was confronted with the
identical set of cases. Moreover, the expert panel
scored cases preceding the study, independent of the
results of the primary care physicians, thereby
eliminating a potential bias which might have been
overlooked in previous studies.5,14,15
In this study we demonstrated that the novel
method of combining standardised case material
with techniques of multi-level analysis may be useful
to evaluate complex diagnostic tools, like spirome-
try. We conclude that trained GPs were able to
differentiate between normal and obstructive dis-
ease patterns, while FV curves suggestive of rare
and mixed pathology were often missed. Spirometry
seems to influence the decision-making process of
the GP by reducing diagnostic uncertainty but
increasing use of additional diagnostics and referral
to specialist care. Whether this represents an initial
or a more sustained effect remains to be evaluated
in studies of daily primary care practice.
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